The University of Kansas Center for Research, Inc. was awarded a $24,000 firm fixed price purchase order by the National Institutes of Health's National Center for Advancing Translational Sciences to conduct feasibility testing for a topically applied formulation for rodent testing of bacterial elongation factor inhibitors. The testing will support the agency's efforts to develop new antibiotics by evaluating delivery methods for candidate compounds. No subcontractors or set aside designations...
The University of Kansas Center for Research, Inc. was awarded a $38,500 firm fixed-price purchase order by the National Institutes of Health's National Center for Advancing Translational Sciences to provide formulation strategy and preclinical support services for a lead compound. Per the solicitation, the contractor will develop a formulation strategy, support preclinical studies, support IND-enabling studies, and submit evidence of its capabilities and a price proposal. The purpose is to...
This firm fixed-price purchase order for $22,500 was awarded by the Department of Health and Human Services National Institutes of Health National Center for Advancing Translational Sciences to the University of Kansas Center for Research Inc. to conduct feasibility testing for solid dosage form strategy options for GPR110 agonist A8. The prime contractor will perform spray drying and adsorption techniques to generate powders from drug-polymer mixtures, emulsions, and suspensions with various...
This $23,800.00 firm fixed-price purchase order was awarded by the National Center for Advancing Translational Sciences (NCATS), a civilian federal agency, to the University of Kansas Center for Research Inc. on September 12, 2024. The contract is for preliminary solid dosage form development strategy of an ALDH1A1 inhibitor drug candidate for NCATS' Extramural Research and Training Branch (ETB). This contract does not have a set-aside designation. The University of Kansas Center for Research...
The Department of Health and Human Services' National Institutes of Health National Institute on Drug Abuse awarded a firm fixed-price purchase order valued at $22,500 to the University of Kansas Center for Research, Inc. This award is pursuant to a request for quote to develop a manufacturable tablet formulation of the compound NCGC72 for use in dog sarcoma clinical studies. The prime contractor will non-GMP manufacture 1,500 tablets total, with 1,000 tablets at 50mg dosage and 500 tablets at...
This federal contract award was made by the National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health (NIH) to the University of Kansas Center for Research Inc., a non-profit subsidiary of the University of Kansas. The $7,070.00 firm fixed-price purchase order is for laboratory equipment and supplies, with a completion date of December 27, 2013. The award does not have a set-aside designation. The University of Kansas Center for Research Inc. frequently...
This is a definitive contract awarded by the Department of Health and Human Services' National Institutes of Health (NIH) National Institute of Diabetes and Digestive and Kidney Diseases to the University of Kansas Center for Research Inc., a non-profit subsidiary of the University of Kansas. The $20,644,637.00 contract is for the delivery of "DESTROYERS" and does not have a set-aside designation. The University of Kansas Center for Research Inc. is an experienced institution that...
This is a firm fixed price purchase order awarded by the National Institutes of Health (NIH) to the University of Kansas Center for Research Inc., a non-profit subsidiary of the University of Kansas. The $20,000.00 contract supports structural studies of cofactor-independent phosphoglycerate mutases (iPGMs), which are enzymes involved in glycolysis. As the prime contractor, the University of Kansas Center for Research Inc. will perform this research. The award does not have a set-aside...
The Department of Health and Human Services National Institutes of Health National Center for Advancing Translational Sciences awarded a $108,000 purchase order to Pharmaron, Inc. for pharmacokinetics experiments involving forty rodents across two study arms. The one-year contract has Pharmaron performing the work in China under a firm fixed price arrangement. No additional details were provided on subcontractors or the specific NIH programs the research aims to support. The award information...
The Department of Health and Human Services National Institutes of Health National Center for Advancing Translational Sciences awarded a $92,605 firm fixed price delivery order to Mriglobal, doing business as Midwest Research Institute, an independent not-for-profit research organization. The order is part of the $100 million IDIQ contract vehicle from HHS ASPR to maintain nonclinical laboratory networks evaluating medical countermeasures. This delivery order is for ML-246 (METARRESTIN)...